AV-101 (Dry Powder Inhaled Imatinib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AV-101 (Dry Powder Inhaled Imatinib), covering 2024-08-23 to 2024-08-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH) [Phase 2, Phase 3]